Related Experiment Videos
Genetic analysis of Batten disease
1Department of Paediatrics, University College London Medical School, Rayne Institute, UK.
Journal of Inherited Metabolic Disease
|January 1, 1993
Summary
Batten disease, a neurodegenerative disorder, involves lipopigment accumulation. Positional cloning efforts are identifying genetic loci for infantile (CLN1) and juvenile (CLN3) forms, aiding prenatal diagnosis.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Batten disease, or neuronal ceroid-lipofuscinosis (CLN), is a group of inherited neurodegenerative disorders.
- It is characterized by the accumulation of autofluorescent lipopigment in neurons, primarily affecting children.
- The underlying biochemical defect remains largely unknown.
Purpose of the Study:
- To elucidate the molecular basis of Batten disease using positional cloning strategies.
- To identify the specific genes responsible for different forms of the disease, including infantile (CLN1) and juvenile (CLN3) varieties.
Main Methods:
- Linkage analysis was employed to map disease loci.
- Identification of marker loci in strong linkage disequilibrium with disease loci.
- Demonstration of locus heterogeneity between different CLN types.
Main Results:
- The infantile disease locus (CLN1) was mapped to human chromosome 1p32.
- The juvenile disease locus (CLN3) was mapped to human chromosome 16p12.
- Locus heterogeneity was confirmed between classical late-infantile CLN (CLN2) and CLN1/CLN3.
Conclusions:
- Positional cloning is a viable strategy for identifying Batten disease genes.
- Linked markers offer a new avenue for prenatal diagnosis of CLN.
- Further research is ongoing to clone CLN1 and CLN3 and map CLN2.